Prognosis of diffuse (non-nodular) non-Hodgkin's lymphoma
Rudders, R.A.; Hensleigh, D.
Cancer ChemoTherapy Reports 59(2 Part 1): 421-424
1975
ISSN/ISBN: 0069-0112 PMID: 1149011 Document Number: 83139
Document emailed within 1 workday
Related Documents
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91Siddiqui, N.; Al-Diab, A.I. 2005: Nodular lymphocyte predominant Hodgkin's lymphoma Saudi Medical Journal 26(2): 241-245
Chubachi, A.; Miura, A.B.; Takatsu, H.; Yamaguchi, A.; Nishimura, S.; Nakayama, Y.; Akihama, T.; Miura, S.; Saitoh, M.; Watanuki, T. 1991: Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(8): 1303-1309
Ricevuti, G.; Balduini, C.L.; Gozzoli, L.; Piccolo, G.; Ricevuti, G.P.; Rognone, F.; Rizzo, S.C. 1982: Computed tomography (CT) detection of a diffuse periventricular subependymal lesion in a case of Hodgkin's lymphoma (subependymal lymphoma) Haematologica 67(5): 769-774
Pirc-Danoewinata, H.; Chott, A.; Onderka, E.; Drach, J.; Schlögl, E.; Jäger, U.; Thalhammer, F.; Nowotny, H.; Aryee, D.; Steger, G.G. 1994: Karyotype and prognosis in non-Hodgkin lymphoma Leukemia 8(11): 1929-1939
Guo, H.-Y.; Zhao, X.-M.; Cao, J.-N.; Hu, X.-C.; Yin, J.-L.; Hong, X.-N.; Li, J. 2008: Prognosis of primary non-Hodgkin's lymphoma of the breast Zhonghua Zhong Liu Za Zhi 30(3): 200-202
Maseki, N. 1992: Chromosome abnormalities and prognosis in non-Hodgkin's lymphoma Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1293-1297
Abdou, A.G.; Kandil, M.; Eldien, M.S.; Abdallah, R. 2016: Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma Pathologica 108(3): 140-143
O'Sullivan, C.C.; Ozdemirli, M.; Bazylewicz, M.; Cheson, B.D. 2013: Complete response to brentuximab vedotin in a transplant-naïve patient with relapsed CD30-positive nodular lymphocyte-predominant Hodgkin lymphoma Clinical Advances in Hematology and Oncology: H&o 11(6): 382-385
Feil, W.; Wenzl, E.; Radaskiewicz, T.; Schiessel, R. 1987: Non-Hodgkin's lymphoma of the stomach: surgical therapy and prognosis Wiener Klinische Wochenschrift 99(12): 426-430
Sabourin, G. 2012: Non-Hodgkin's lymphoma: a new less toxic treatment doubles the prognosis Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 9(6): 60
Riabukhina, I.E.; Larionova, V.B.; Demina, E.A.; Dmitrieva, N.V. 2007: Infectious complications in patients with Hodgkin's lymphoma of unfavourable prognosis Antibiotiki i Khimioterapiia 52(1-2): 28-38
Zhang, H.-w.; Chen, Z.-w.; Wang, J.-f.; Cheng, N.-l. 2011: Significance of CD138 in immunohistochemical profiles and its correlation with prognosis in diffuse large B-cell lymphoma Zhonghua Zhong Liu Za Zhi 33(2): 115-120
Laing, R.J.; Jakubowski, J.; Kunkler, I.H.; Hancock, B.W. 1992: Primary spinal presentation of non-Hodgkin's lymphoma. A reappraisal of management and prognosis Spine 17(1): 117-120
Pignat, J.C.; Haguenauer, J.P.; Ghouila, C.; Gaillard, J. 1989: Cervicofacial non-Hodgkin's malignant lymphoma. Classification, prognosis and treatment apropos of 65 cases Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 106(1): 37-39
Landgren, O.; Algernon, C.; Axdorph, U.; Nilsson, B.; Wedelin, C.; Porwit-MacDonald, A.; Grimfors, G.; Björkholm, M. 2003: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis Haematologica 88(4): 438-444
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Kovrigina, A.M.; Probatova, N.A.; Pavlovskaia, A.I.; Tupitsyn, N.N.; Sholokhova, E.N.; Tumian, G.S. 2003: Hodgkin lymphoma with lymphoid predominance: differential diagnosis of nodular lymphoid predominance and classical variant Arkhiv Patologii 65(4): 3-8
Calderoni, P.; Sudanese, A.; Bettelli, G.; Dallari, D.; Picci, P.; Leonessa, C.; Capanna, R.; Campanacci, M.; Bacci, G. 1985: Staging, therapy and prognosis of non-Hodgkin's primary lymphoma of bone (or bone reticulosarcoma): experience of the Rizzoli Orthopedic Institute in relation to 30 cases treated in the last 10 years La Chirurgia Degli Organi di Movimento 70(3): 231-239
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166